Lighthouse Medical Communications US, a subsidiary of the Lucid Group companies, has named Marc Pondel as its executive medical science director, it was reported yesterday.

In the new role, Pondel will guide the Lighthouse medical writing teams as he brings scientific and clinical strategic insight knowledge for the agency's clients. His career has seen him serve in various senior-level strategic medical and advisory positions, leading teams in a number of key therapeutic areas.

Andy Willmer, managing director of Lighthouse, said, 'As Lighthouse expands its footprint in the USA we must ensure we build a platform of scientific capability that can continually deliver magical programmes for our clients. Dr Pondel brings not only a background of scientific excellence but a rich experience of creative communication approaches, which can truly impact patient outcomes.'